BIOFIL CHEM & PHARMA LTD
BIOFILCHEM · General/Diversified · NSE
₹33
Current Market Price
Fair Value (DCF)
₹12
Margin of Safety
-63.7%
Updated 5h ago
YieldIQ Score
15/100
Piotroski F-Score
4/9
Economic Moat
None
Confidence
24%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹54 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
400.0%
Return on capital employed
EV / EBITDA
14.6×
Enterprise multiple
Debt / EBITDA
0.1×
Leverage vs earnings
Interest Coverage
19.2×
EBIT covers interest
Current Ratio
1.34×
Short-term liquidity
Asset Turnover
0.66×
Revenue per ₹ of assets
Revenue CAGR (3Y)
14.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹33.22
Bear case
₹8.18
MoS -306.1%
Base case
₹12.05
MoS -175.7%
Bull case
₹16.65
MoS -99.5%
Ratio Trends
BIOFILCHEM · last 4 annual periods
ROE
3.0%
ROCE
6.0%
Operating Margin
—
Debt / Equity
0.03×
PE
120.2×
EV / EBITDA
53.7×
Historical Financials
BIOFILCHEM · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹35.8 Cr | ₹22.4 Cr | ₹30.0 Cr | ₹40.0 Cr | ₹33.4 Cr | -1.7% |
| EBITDA | — | ₹1.5 Cr | ₹1.3 Cr | ₹1.3 Cr | ₹1.2 Cr | -6.2% |
| EBIT | ₹2.0 Cr | ₹1.1 Cr | ₹0.8 Cr | ₹0.9 Cr | — | -17.9% |
| PAT | ₹1.2 Cr | ₹0.7 Cr | ₹0.6 Cr | ₹0.7 Cr | ₹0.6 Cr | -18.2% |
| EPS (diluted) | ₹0.76 | ₹0.44 | ₹0.29 | ₹0.44 | — | -12.8% |
| CFO | ₹1.1 Cr | ₹-0.2 Cr | ₹-0.1 Cr | ₹2.4 Cr | ₹-1.9 Cr | — |
| CapEx | — | — | — | — | ₹-0.1 Cr | — |
| FCF | — | — | — | — | ₹-2.0 Cr | — |
| Total Assets | — | ₹18.7 Cr | ₹31.4 Cr | ₹47.1 Cr | ₹51.0 Cr | +28.4% |
| Total Debt | — | — | ₹0.5 Cr | ₹0.4 Cr | ₹0.5 Cr | -2.5% |
| Shareholders' Equity | — | — | ₹17.3 Cr | ₹18.2 Cr | ₹18.8 Cr | +2.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
BIOFILCHEM vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| VIVIMEDLAB VIVIMEDLAB | — | — | Pending | 90.9% | — |
| MANGALAM MANGALAM | — | — | Pending | 4.5% | — |
| LASA LASA | — | — | Pending | -17.6% | — |
| VAISHALI VAISHALI | — | — | Pending | 1.3% | — |
| PAR PAR | — | — | Pending | 13.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for BIOFILCHEM in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of BIOFILCHEM →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for BIOFILCHEM →
Compare
Head-to-head with peers
Compare BIOFILCHEM side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse BIOFILCHEMNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.